miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis
Open Access
- 12 February 2021
- Vol. 12 (2), 267
- https://doi.org/10.3390/genes12020267
Abstract
Breast cancer is the most common women’s malignancy in the world and, for subgroups of patients, treatment outcomes remain poor. Thus, more effective therapeutic strategies are urgently needed. MicroRNAs (miRNAs) have emerged as promising therapeutic tools and targets, as they play significant roles in regulating key cellular processes by suppressing gene expression. However, additive opportunities involving miRNAs have been underexplored. For example, both miR-34a and miR-200c individually suppress the development of different types of cancer, but the cellular effects of their combined actions remain unknown. Here, we show that miR-34a and miR-200c levels are reduced in breast tumors compared to adjacent normal tissues and that this additively predicts poor patient survival. In addition, in cell lines, miR-34a and miR-200c additively induce apoptosis and cell cycle arrest, while also inhibiting proliferation, invasion, migration, stemness and epithelial-to-mesenchymal transition (EMT). Mechanistically, both miRNA-34a and miR-200c directly target HIF1-α and subsequently downregulate VEGFR, MMP9 and CXCR4, although combined miRNA-34a and miR-200c delivery suppresses mouse xenograft tumor development as effectively as individual delivery. We establish a model, supported by in vitro and clinical data, which collectively suggest that the co-delivery of miR-34a and miR-200c represents a promising novel therapeutic strategy for breast cancer patients.Funding Information
- Tabriz University of Medical Sciences (700/95)
This publication has 61 references indexed in Scilit:
- MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transitionJournal of Ovarian Research, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Re: The MicroRNA miR-34a Inhibits Prostate Cancer Stem Cells and Metastasis by Directly Repressing CD44Journal of Urology, 2011
- MicroRNA Regulation of Cancer Stem CellsCancer Research, 2011
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Nature Medicine, 2011
- Overexpression of MMP-9 and HIF-1α in Breast Cancer Cells under Hypoxic ConditionsJournal of Breast Cancer, 2011
- MicroRNA-34a regulation of endothelial senescenceBiochemical and Biophysical Research Communications, 2010
- Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samplesBiochemical and Biophysical Research Communications, 2009
- Role of liposomal anthracyclines in breast cancerAnnals of Oncology, 2007
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005